Meyka Pro banner
Mallinckrodt plc

Mallinckrodt plc (MNK) Stock Overview

Explore Mallinckrodt plc’s financial performance, market position, analyst ratings, and future outlook.

MNKAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.34
$0.06(14.97%)
U.S. Market is Open · 13:55

Mallinckrodt plc (MNK)

Meyka AI Score

Z

Key Financials

Market Cap4.5M
P/E Ratio-0.01
EPS (TTM)$-0.78
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

MNK Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Mallinckrodt plc (AMEX: MNK) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Mallinckrodt plc's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MNK on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.

Key metrics behind Mallinckrodt plc's AMEX-traded stock include a P/E ratio of -0.01 and a market capitalization of 4.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MNK on the AMEX.

Price Performance (AMEX: MNK)

1-Day Change
N/A
5-Day Change
207.32%
1-Month Change
-14.97%
3-Month Change
-74.03%
6-Month Change
-95.77%
Year-to-Date (YTD) Change
-95.62%
1-Year Change
-97.80%
3-Year Change
-97.80%
5-Year Change
-97.80%
All-Time (Max) Change
-97.80%

Contact Information

353 1 696 0000
College Business & Technology Park, Dublin, NaN, 15

Company Facts

26,730 Employees
IPO DateJun 21, 2022
CountryIE

Frequently Asked Questions